Design Therapeautics, Inc. Share Price: DSGN (Design Therapeautics, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Design Therapeautics, Inc. share price today?

Accepted Answer

Design Therapeautics, Inc. (DSGN) share price today is {{live_price}}.

Question 2

Can Indians buy Design Therapeautics, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Design Therapeautics, Inc. (DSGN) from India.

With INDmoney, you can buy Design Therapeautics, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Design Therapeautics, Inc. at zero transaction cost.

Question 3

How can I buy Design Therapeautics, Inc. shares from India?

Accepted Answer

It is very easy to buy Design Therapeautics, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Design Therapeautics, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Design Therapeautics, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Design Therapeautics, Inc. stocks?

Accepted Answer

To start investing in Design Therapeautics, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Design Therapeautics, Inc.

Accepted Answer

Today’s highest price of Design Therapeautics, Inc. (DSGN) is {{1_rba_end}}.

Today’s lowest price of Design Therapeautics, Inc. (DSGN) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Design Therapeautics, Inc.

Accepted Answer

Today's market capitalisation of Design Therapeautics, Inc. DSGN is 264.4M

Question 8

What is the 52 Week High and Low Range of Design Therapeautics, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Design Therapeautics, Inc. is down from its 52 Week High?

Accepted Answer

Design Therapeautics, Inc. (DSGN) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Design Therapeautics, Inc. is up from its 52 Week low?

Accepted Answer

Design Therapeautics, Inc. (DSGN) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Design Therapeautics, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Design Therapeautics, Inc.

Accepted Answer

Mr. Pratik  Shah Ph.D. is the current Chief Executive Officer (CEO) of Design Therapeautics, Inc..

Period	Design Therapeautics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	21.3%	5.1%	0.0%
6 Months	63.86%	4.9%	0.0%
1 Year	77.57%	16.6%	0.0%
3 Years	-73.47%	13.2%	-22.3%

Market Capitalization	264.4M
Book Value	$4.61
Earnings Per Share (EPS)	-0.9
Wall Street Target Price	7.0

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-13.63%
Return On Equity TTM	-18.11%

Revenue TTM	33.0K
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	-48.6M
EBITDA	-62.8M
Diluted Eps TTM	-0.9
Quarterly Earnings Growth YOY	0.0

Design Therapeautics, Inc. (DSGN)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs NVO

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.91
EPS Estimate Next Year	-1.17
EPS Estimate Current Quarter	-0.23
EPS Estimate Next Quarter	-0.25

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Design Therapeautics, Inc.	14.46%	63.86%	77.57%	-73.47%	-88.74%
Regeneron Pharmaceuticals, Inc.	5.97%	16.25%	37.11%	69.18%	305.56%
Novo Nordisk A/s	9.99%	-3.52%	34.24%	158.74%	417.73%
Alnylam Pharmaceuticals, Inc.	-5.15%	64.67%	22.72%	31.08%	198.44%
Vertex Pharmaceuticals Incorporated	0.45%	14.0%	36.06%	143.5%	167.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Design Therapeautics, Inc.	NA	NA	NA	-0.91	-0.18	-0.14	NA	4.61
Regeneron Pharmaceuticals, Inc.	29.93	29.93	1.54	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	44.01	44.01	1.98	3.44	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.55	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.57	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Design Therapeautics, Inc.	Hold	$264.4M	-88.74%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$124.7B	305.56%	29.93	32.04%
Novo Nordisk A/s	Buy	$585.3B	417.73%	44.01	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$32.3B	198.44%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$120.9B	167.72%	32.84	-4.74%

Organization	Design Therapeautics, Inc.
Employees	57
CEO	Mr. Pratik Shah Ph.D.
Industry	Healthcare